These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology. Fishman J, Martucci C. J Clin Endocrinol Metab; 1980 Sep; 51(3):611-5. PubMed ID: 7190977 [Abstract] [Full Text] [Related]
4. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding. Zhu BT, Han GZ, Shim JY, Wen Y, Jiang XR. Endocrinology; 2006 Sep; 147(9):4132-50. PubMed ID: 16728493 [Abstract] [Full Text] [Related]
8. Neonatal estrogen decreases neural density of the septum-midbrain central gray connection underlying the lordosis-inhibiting system in female rats. Tsukahara S, Ezawa N, Yamanouchi K. Neuroendocrinology; 2003 Oct; 78(4):226-33. PubMed ID: 14583655 [Abstract] [Full Text] [Related]
16. Tissue-selective effects of continuous release of 2-hydroxyestrone and 16alpha-hydroxyestrone on bone, uterus and mammary gland in ovariectomized growing rats. Lotinun S, Westerlind KC, Turner RT. J Endocrinol; 2001 Jul; 170(1):165-74. PubMed ID: 11431149 [Abstract] [Full Text] [Related]
17. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Swaneck GE, Fishman J. Proc Natl Acad Sci U S A; 1988 Nov; 85(21):7831-5. PubMed ID: 3186693 [Abstract] [Full Text] [Related]
18. Impact of continuously administered catechol estrogens on uterine growth and luteinizing hormone secretion. Martucci CP, Fishman J. Endocrinology; 1979 Dec; 105(6):1288-92. PubMed ID: 499073 [Abstract] [Full Text] [Related]